Novartis has boosted its profit forecast due to strong sales of new drugs. The company reported a 15% increase in quarterly earnings, driven by the success of medications like Afinitor and Gilenya. This growth is expected to continue, with Novartis now predicting higher profits for the full year.

Source: https://www.bloomberg.com/news/articles/2024-10-29/novartis-boosts-profit-forecast-as-sales-of-new-drugs-rise